137 related articles for article (PubMed ID: 30826588)
1. Development of a series of 4-hydroxycoumarin platinum(IV) hybrids as antitumor agents: Synthesis, biological evaluation and action mechanism investigation.
Li G; Zhang J; Liu Z; Wang Q; Chen Y; Liu M; Li D; Han J; Wang B
J Inorg Biochem; 2019 May; 194():34-43. PubMed ID: 30826588
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of bi-functional 7-hydroxycoumarin platinum(IV) complexes as antitumor agents.
Wang Q; Chen Y; Li G; Liu Z; Ma J; Liu M; Li D; Han J; Wang B
Bioorg Med Chem; 2019 May; 27(10):2112-2121. PubMed ID: 30981607
[TBL] [Abstract][Full Text] [Related]
3. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
Wang H; Yang X; Zhao C; Wang PG; Wang X
Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of a new series of low toxic naphthalimide platinum(IV) antitumor complexes with dual DNA damage mechanism.
Wang Q; Tan X; Liu Z; Li G; Zhang R; Wei J; Wang S; Li D; Wang B; Han J
Eur J Pharm Sci; 2018 Nov; 124():127-136. PubMed ID: 30153524
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents.
Wang Q; Huang Z; Ma J; Lu X; Zhang L; Wang X; George Wang P
Dalton Trans; 2016 Jun; 45(25):10366-74. PubMed ID: 27252024
[TBL] [Abstract][Full Text] [Related]
6. A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells.
Wang Q; Chen Y; Li G; Zhao Y; Liu Z; Zhang R; Liu M; Li D; Han J
Bioorg Med Chem Lett; 2019 Oct; 29(20):126670. PubMed ID: 31500997
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
[TBL] [Abstract][Full Text] [Related]
8. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
Chen Y; Wang Q; Li Z; Liu Z; Zhao Y; Zhang J; Liu M; Wang Z; Li D; Han J
Dalton Trans; 2020 Apr; 49(16):5192-5204. PubMed ID: 32236281
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of 4-hydroxycoumarin derivatives.
Jung JC; Lee JH; Oh S; Lee JG; Park OS
Bioorg Med Chem Lett; 2004 Nov; 14(22):5527-31. PubMed ID: 15482917
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
11. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents.
Sun Y; Wei H; Zhang Q; Zhao X
Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism.
Liu Z; Li Z; Du T; Chen Y; Wang Q; Li G; Liu M; Zhang N; Li D; Han J
Dalton Trans; 2021 Jan; 50(1):362-375. PubMed ID: 33319888
[TBL] [Abstract][Full Text] [Related]
13. Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells.
Almotairy ARZ; Montagner D; Morrison L; Devereux M; Howe O; Erxleben A
J Inorg Biochem; 2020 Sep; 210():111125. PubMed ID: 32521289
[TBL] [Abstract][Full Text] [Related]
14. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
Zhou Z; Chen F; Xu G; Gou S
Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
[TBL] [Abstract][Full Text] [Related]
15. Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes.
Annunziata A; Amoresano A; Cucciolito ME; Esposito R; Ferraro G; Iacobucci I; Imbimbo P; Lucignano R; Melchiorre M; Monti M; Scognamiglio C; Tuzi A; Monti DM; Merlino A; Ruffo F
Inorg Chem; 2020 Mar; 59(6):4002-4014. PubMed ID: 32129608
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
17. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
[TBL] [Abstract][Full Text] [Related]
18. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
19. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
Bioorg Med Chem; 2017 Sep; 25(17):4686-4700. PubMed ID: 28728896
[TBL] [Abstract][Full Text] [Related]
20. Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo.
Li L; Chen Y; Wang Q; Li Z; Liu Z; Hua X; Han J; Chang C; Wang Z; Li D
Int J Nanomedicine; 2021; 16():5513-5529. PubMed ID: 34429597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
